Patrick D. Yeramian - Chief Medical Officer at Amylyx Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick D. Yeramian since 1/12/2024

Holdings reported by Patrick D. Yeramian for Amylyx Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 206K $3.36M $16.33 Jan 9, 2024 Direct
Stock Option (right to buy) 33.8K May 15, 2023 Direct Common Stock

Transactions reported by Patrick D. Yeramian for Amylyx Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.